The proportion of participants achieving HbA1c < 7.0% and a =10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide ...
GLP-1 RA use was associated with improved cardiometabolic outcomes among pediatric patients with type 2 diabetes and obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback